Editorial: Gynecological and gastrointestinal cancers: Recent advances in molecular diagnosis and targeted therapy.
作者信息
Zhang Lan, Wang Guan, Zhu Lingjuan, Wei Wei, Zhang Jin
机构信息
Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, China.
State Key Laboratory of Biotherapy and Cancer Center, Nursing Key Laboratory of Sichuan Province, Innovation Center of Nursing Research, West China Hospital, and Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu, China.
出版信息
Front Mol Biosci. 2023 Mar 3;10:1167337. doi: 10.3389/fmolb.2023.1167337. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Gynecological and gastrointestinal cancers: Recent advances in molecular diagnosis and targeted therapy.社论：妇科与胃肠道癌症：分子诊断与靶向治疗的最新进展
Front Mol Biosci. 2023 Mar 3;10:1167337. doi: 10.3389/fmolb.2023.1167337. eCollection 2023.
2
Advances in Hereditary Colorectal and Pancreatic Cancers.遗传性结直肠癌和胰腺癌的进展
Clin Ther. 2016 Jul;38(7):1600-21. doi: 10.1016/j.clinthera.2016.03.017. Epub 2016 Apr 2.
3
Pancreatic adenocarcinoma: molecular drivers and the role of targeted therapy.胰腺导管腺癌：分子驱动因素和靶向治疗的作用。
Cancer Metastasis Rev. 2021 Mar;40(1):355-371. doi: 10.1007/s10555-020-09948-w. Epub 2021 Jan 4.
4
Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers.肿瘤相关巨噬细胞失调在妇科和乳腺癌的发生、发展及靶向治疗中的作用。
J Hematol Oncol. 2021 Oct 30;14(1):181. doi: 10.1186/s13045-021-01198-9.
5
Follow-up routines in gynecological cancer - time for a change?妇科癌症的随访常规——是时候改变了吗？
Acta Obstet Gynecol Scand. 2011 Jul;90(7):707-18. doi: 10.1111/j.1600-0412.2011.01123.x. Epub 2011 Apr 15.
6
Targeted therapies for pancreatic adenocarcinoma: Where do we stand, how far can we go?胰腺癌的靶向治疗：我们目前的状况如何，我们能走多远？
World J Gastrointest Oncol. 2015 Oct 15;7(10):172-7. doi: 10.4251/wjgo.v7.i10.172.
7
Immune checkpoint blockades in gynecological cancers: A review of clinical trials.妇科恶性肿瘤的免疫检查点抑制剂治疗：临床试验研究进展。
Acta Obstet Gynecol Scand. 2022 Sep;101(9):941-951. doi: 10.1111/aogs.14412. Epub 2022 Jun 25.
8
Editorial: Advances in genetics and molecular diagnosis in colorectal, stomach, and pancreatic cancer.社论：结直肠癌、胃癌和胰腺癌的遗传学与分子诊断进展
Front Oncol. 2022 Dec 19;12:1104671. doi: 10.3389/fonc.2022.1104671. eCollection 2022.
9
Current and future therapies for targeting HER2 mutations in gastrointestinal cancer.针对胃肠道癌中 HER2 突变的当前和未来治疗方法。
Expert Rev Anticancer Ther. 2018 Nov;18(11):1085-1092. doi: 10.1080/14737140.2018.1510324. Epub 2018 Aug 21.
10
Editorial: Advances in genetics and molecular diagnosis in colorectal, stomach, and pancreatic cancer vol II.社论：结直肠癌、胃癌和胰腺癌的遗传学与分子诊断进展 第二卷
Front Oncol. 2024 Jul 10;14:1448183. doi: 10.3389/fonc.2024.1448183. eCollection 2024.
本文引用的文献
1
APOBEC-Induced Mutagenesis in Cancer.载脂蛋白B编辑复合体诱导的癌症诱变
Annu Rev Genet. 2022 Nov 30;56:229-252. doi: 10.1146/annurev-genet-072920-035840. Epub 2022 Aug 26.
2
Repurposing gestrinone for tumor suppressor through P21 reduction regulated by JNK in gynecological cancer.通过JNK调节的P21减少将孕三烯酮重新用于妇科癌症中的肿瘤抑制
Transl Res. 2022 May;243:21-32. doi: 10.1016/j.trsl.2021.12.002. Epub 2021 Dec 16.
3
miR-802 Suppresses Acinar-to-Ductal Reprogramming During Early Pancreatitis and Pancreatic Carcinogenesis.miR-802 抑制胰腺炎早期和胰腺癌发生过程中的腺泡到导管的重编程。
Gastroenterology. 2022 Jan;162(1):269-284. doi: 10.1053/j.gastro.2021.09.029. Epub 2021 Sep 20.
4
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments.上皮性卵巢癌的化疗耐药：机制与新的治疗方法。
Semin Cancer Biol. 2021 Dec;77:144-166. doi: 10.1016/j.semcancer.2021.08.011. Epub 2021 Aug 28.
5
Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers.化疗与免疫治疗在胃食管癌症中的协同作用。
Cancer Lett. 2020 Dec 28;495:89-99. doi: 10.1016/j.canlet.2020.09.014. Epub 2020 Sep 17.
6
Breast cancer: Biology, biomarkers, and treatments.乳腺癌：生物学、生物标志物和治疗方法。
Int Immunopharmacol. 2020 Jul;84:106535. doi: 10.1016/j.intimp.2020.106535. Epub 2020 Apr 29.
7
Colorectal cancer.结直肠癌。
Lancet. 2019 Oct 19;394(10207):1467-1480. doi: 10.1016/S0140-6736(19)32319-0.
8
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer.环状 RNA_0025202 通过调控 miR-182-5p/FOXO3a 轴调控乳腺癌他莫昔芬敏感性和肿瘤进展。
Mol Ther. 2019 Sep 4;27(9):1638-1652. doi: 10.1016/j.ymthe.2019.05.011. Epub 2019 May 17.
9
Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions.肥胖与胃肠道癌症：流行病学、发病机制及未来研究方向。
Nat Rev Gastroenterol Hepatol. 2018 Nov;15(11):659-670. doi: 10.1038/s41575-018-0038-1.
10
Awareness and current knowledge of breast cancer.对乳腺癌的认识及当前知识
Biol Res. 2017 Oct 2;50(1):33. doi: 10.1186/s40659-017-0140-9.
Zotero 插件